Related Experiment Video
Updated: Jun 17, 2026
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Prenatal hair development: implications for drug exposure determination.
1Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada. joey.gareri@sickkids.ca
Forensic Science International
|January 16, 2010
Summary
Neonatal hair analysis helps determine drug exposure during pregnancy. Understanding fetal hair development is key to accurately interpreting toxicological results from newborn hair.
Area of Science:
- Toxicology
- Developmental Biology
- Forensic Science
Background:
- Neonatal hair serves as a crucial toxicological matrix for assessing in utero drug exposure.
- Accurate toxicological analysis of neonatal hair relies on understanding hair growth cycles.
Purpose of the Study:
- To review the physiological development of the hair follicle and hair production during fetal life.
- To highlight the importance of prenatal hair development knowledge for toxicological assessments.
Main Methods:
- Literature review of physiological hair development during fetal life.
- Analysis of the timing and mechanisms of prenatal hair production.
Main Results:
- Detailed review of the stages of hair follicle morphogenesis and keratinization in utero.
- Established the critical prenatal time windows for hair shaft formation.
Conclusions:
- Understanding fetal hair development is essential for interpreting drug exposure data from neonatal hair.
- This knowledge refines the accuracy of toxicological analyses, improving prenatal exposure assessments.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:10Drug Excretion: Miscellaneous Routes
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...